All SARS-Cov-2

Ultrastructural morphology exhibited by the 2019 Novel Coronavirus

March 24, 2021

Novel COVID-19 drug blocks viral replication

Rational drug design pays off

Ultrastructural morphology exhibited by the 2019 Novel Coronavirus

February 2, 2021

Retrained generic antibodies can recognize SARS-CoV-2

Hepatitis B antibody is a good choice for recognizing new virus

April 23, 2020

Computer simulations explore potential COVID-19 therapeutics

Identifying inhibitors could lead to new medicines to combat the coronavirus